CHRISTOPHER MITCHELL: Open Payments
NPI 1972583375 · MAYFIELD HEIGHTS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,655 in 172 payments from 27 companies in 2025. Trend: 2023 $2,365 · 2024 $3,151 · 2025 $3,655
Food & beverage: $3,648Education: $7
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 37 | $566 |
| AstraZeneca Pharmaceuticals LP | 22 | $525 |
| CSL Behring | 15 | $343 |
| GENZYME CORPORATION | 12 | $336 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $271 |
| Regeneron Healthcare Solutions, Inc. | 7 | $193 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $178 |
| Amgen Inc. | 11 | $169 |
| Novartis Pharmaceuticals Corporation | 8 | $160 |
| Octapharma USA, Inc. | 7 | $147 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, XOLAIR, TAKHZYRO, NEFFY, Hizentra, TRELEGY ELLIPTA.
Industry payments across OH — which companies pay providers there.
